Duration: CME/CE Points: Author(s):
Contact Hours : 1

Residual Neuromuscular Blockade in the Critical Care Setting is organized by American Association of Critical - Care Nurses (AACN) and will be held during Mar 01, 2018 - Mar 01, 2021.

Accreditation :
The American Association of Critical-Care Nurses (AACN) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s (ANCC's) Commission on Accreditation, ANCC Provider Number 0012 (60 min contact hour). AACN has been approved as a provider of continuing education in nursing by the California State Board of Nursing, California Provider number CEP01036 for 1.2 contact hours (50 min contact hour).

Activity Summary :
The article includes a review of the current uses for the neuromuscular blockade, pathophysiology of the neuromuscular junction, pharmacologic characteristics of neuromuscular blocking agents (including drug-drug interactions), monitoring modalities, and effectiveness of reversal agents. Treatment recommendations pertinent to residual neuromuscular blockade are outlined.

Objectives :
• Facilitate the safe recovery of patients undergoing general anesthesia.
• Identify early signs of deterioration, complications, and patient risk factors associated with residual paralysis.
• Evaluate treatment interventions for those patients with evidence of residual neuromuscular blockade.

Additional details will be posted as soon as they are available.

Target Audience

Critical Care Medicine, Clinical Pharmacology, Nurse anesthesia


Activity Fee : USD $10.00


Critical Care Medicine, Clinical Pharmacology, Nurse anesthesia

Onsite to Virtual Conference

Market your online event to Million plus Healthcare professionals.